Argon Alleviates Bone Cancer Pain by Mitigating Neuronal Ferroptosis via the TLR2-COX-2 Pathway
Open Access
- 25 September 2025
- journal article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (9) , 43761
Abstract
Background: Bone cancer pain (BCP) related neuronal damage is associated with ferroptosis, a regulated cell death dependent on iron. The noble gas argon is known to have neuroprotective effects, reducing neuroinflammation and enhancing neuronal recovery. However, its potential role in alleviating BCP through the modulation of neuronal ferroptosis remains unexplored. Methods: Ferroptosis was induced by Erastin in SH-SY5Y human neuroblastoma cells. Plasmids were used to overexpress or knock down toll-like receptor (TLR) 2 and cyclooxygenase-2 (COX-2). The effects of argon treatment were evaluated in SH-SY5Y cells in which TLR2 and COX-2 expression was manipulated using viability assays, oxidative stress markers (reactive oxygen species (ROS), malondialdehyde (MDA), and glutathione (GSH)), and ferroptosis-related proteins (acyl-CoA synthetase long-chain family member 4 (ACSL4), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11)). In vivo, a murine BCP model was developed by injecting Lewis lung carcinoma cells into the femoral cavity. Pain behaviors were analyzed, and spinal cord ferroptosis features were evaluated using histology, immunofluorescence, and transmission electron microscopy (TEM). Results: In vitro experiments showed that argon treatment restored SH-SY5Y cell viability after Erastin exposure, suppressed ROS and MDA production, and boosted GSH levels. It also downregulated ACSL4 and upregulated GPX4 and SLC7A11. In vivo, argon improved pain behaviors, reduced tumor burden, preserved neuronal integrity, and mitigated ferroptosis-induced damage to the spinal cords of BCP model mice. Argon also significantly suppressed TLR2 and COX-2 expression, disrupting the ferroptosis and inflammation cascades. However, overexpression of TLR2 or COX-2 reversed these protective effects, confirming the pivotal role of the TLR2-COX-2 axis in neuronal ferroptosis and pain modulation. Conclusion: These findings demonstrate that argon effectively mitigates neuronal ferroptosis and alleviates BCP by downregulating the TLR2-COX-2 pathway, highlighting its therapeutic potential for conditions involving ferroptosis, such as cancer-related pain and neurodegenerative diseases.Keywords
Funding Information
- Nantong Health and Wellness Commission’s Scientific Research Program (MS2023063)
- Natural Science Foundation of Nantong Municipality (JCZ2024001)
- Chinese Anti-Cancer Association’s Research Program (GWRX-CR-2024-3)
This publication has 37 references indexed in Scilit:
- Current advances on the role of ferroptosis in tumor immune evasionDiscover Oncology, 2024
- Mechanisms and Therapeutic Potential of GPX4 in Pain ModulationPain and Therapy, 2024
- The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic strokeBrain Research Bulletin, 2024
- Argon neuroprotection in ischemic stroke and its underlying mechanismBrain Research Bulletin, 2024
- Cancer–nerve interplay in cancer progression and cancer-induced bone painJournal of Bone and Mineral Metabolism, 2023
- Cancer induced bone pain: current management and future perspectivesMedical Oncology, 2021
- Ferroptosis is involved in the development of neuropathic pain and allodyniaMolecular and Cellular Biochemistry, 2021
- Inhibition of ferroptosis‐like cell death attenuates neuropathic pain reactions induced by peripheral nerve injury in ratsEuropean journal of pain, 2021
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- The role of TLR2 in nerve injury‐induced neuropathic pain is essentially mediated through macrophages in peripheral inflammatory responseGlia, 2010